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INTRODUCTION: The success of tissue 
engineered grafts relies on a functional blood 
supply developing following implantation. 
Adipose tissue is a rich source of adipose derived 
stem cells (ADSC) which can be collected from 
patients easily and safely. Adipose tissue also 
contains the stromal vascular fraction (SVF), a 
heterogeneous mix of cells including blood cells, 
endothelial cells, stromal cells and ADSC. Both 
ADSC and SVF have been shown to improve 
angiogenesis however very few studies have 
directly compared these two cell populations. Our 
aim is to determine the pro-angiogenic properties 
of ADSC and SVF for use in tissue engineered 
grafts.  
 
METHODS: SVF and ADSC were isolated from 
subcutaneous fat (ethics approval 15/YH/0177) 
using mechanical and enzymatic digestion. ADSC 
were purified from the SVF by adherence to plastic 
and both ADSC and SVF were characterised using 
flow cytometry markers (eBioscience). 5 x105 SVF 
cells or ADSC were cultured in 0.77mg/ml 
Collagen I (rat tail) gels and viability was 
measured by resazurin assay. Conditioned media 
from the gels was collected and a cytokine array 
was performed to quantify the release of proteins 
involved in angiogenesis.  
RESULTS: ADSC and SVF were successfully 
isolated from adipose tissue. ADSC from 3 
different patients were CD31-, CD34-, CD45-, 
CD73+, CD90+, CD105+ and CD146- while the 
SVF contained a heterogeneous cell population in 
line with previous findings (1). SVF and ADSC 
cultured in collagen gels remained viable for 7 day 
in culture. Gels containing ADSC contracted by 
40% compared to control gels without cells; 
however contraction was not observed for gels 
containing SVF. After 24 hours in culture, 
conditioned media from gels containing ADSC and 
SVF showed release of pro-inflammatory 
cytokines including GRO, IL6, IL8, PDGF and 
VEGF-D (Fig 1). Gels containing SVF cells also 
released EGF, PLGF and VEGF-A. A similar 
pattern of expression was observed after 4 days in 
culture (Fig 2).  
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Fig. 1: Cytokine release from collagen gels 
containing SVF and ADSC after 24 hours in 
culture. 
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Fig 2: Cytokine release from collagen gels 
containing SVF and ADSC after 4 days in culture.  
DISCUSSION & CONCLUSIONS: Collagen 
gels containing SVF cells released higher or equal 
levels of pro-angiogenic cytokines when compared 
to gels containing ADSC, with the exception of 
TIMP2 and RANTES. The levels of TIMP2 and 
RANTES may, in part, explain the increased 
contraction observed in these gels. In conclusion 
we have demonstrated SVF cells, which can be 
harvested with less manipulation compared to 
ADSC, may be an attractive alternative to ADSC 
for tissue engineered grafts and that both cell types 
are capable of sustained cytokine release.  
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